Vermillion Announces Equity Financing
Friday, May 10, 2013
Oracle Investment Management, Jack W. Schuler, Matthew W. Strobeck and other investors, have agreed to make an initial investment of $13.2 million by purchasing 8.0 million shares of the Company's common stock.

CardioDx Receives CAP Accreditation
Friday, May 10, 2013
CAP accreditation is awarded to clinical laboratories meeting the highest standards of excellence in quality laboratory practices.

Genetic Test Helps Predict Risk of Prostate Cancer Recurrence
Friday, May 10, 2013
Prostate cancer ranks as the most common internal malignancy diagnosed in men in the United States, but often does not require extensive treatment.

Enzo and NIH File Patent Application for Autoimmune Diseases
Thursday, May 09, 2013
Collaborators filed a patent application for the management of autoimmune diseases that may include age-related macular degeneration (AMD), which is a leading cause of blindness in the United States.

Selventa Strengthens Intellectual Property for SysDx™ Approach to Personalized Medicine
Thursday, May 09, 2013
Patent is core to Selventa’s SysDx™ approach to mining and comparing biological data for predicting a patient’s response or non-response to a drug.

Sydney Based Cellmid Acquires Japanese Advangen
Thursday, May 09, 2013
Strategic acquisition of Japanese healthcare company boosts Cellmid’s cashflow potential.

TriLink BioTechnologies Announces Worldwide License with QuantiBact A/S
Thursday, May 09, 2013
TriLink BioTechnologies Inc. announced that it has signed a licensing agreement with QuantiBact A/S to offer twisted intercalating nucleic acid (TINA) modified oligos.

<<	1 2 3 4 5 6 7	>>
Showing Results 11 - 20 of 1014